Evaluating the cost effectiveness of asthma inhaler systems: An observational study of patients in General Practice in the UK

Journal of Medical Economics

Volumn 10, Issue 3, 2007, Pages 297-308

  Haycox, Alan ^a   Mota, Ruben Mujica ^a   Featherstone, Richard ^b  

^a UNIVERSITY OF LIVERPOOL MANAGEMENT SCHOOL   (United Kingdom)

^b Knowledgeworks   (United Kingdom)

Author keywords

Asthma; Breath actuated; Cost effectiveness; Inhaler

Indexed keywords

SALBUTAMOL;

ADULT; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MILD INTERMITTENT ASTHMA; OBSERVATIONAL STUDY; PRESCRIPTION; SCHOOL CHILD; THERAPY EFFECT; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 34748904152     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990701551298     Document Type: Article

References (23)

1. Jones V, Fernandez C, Diggory P. A comparison of large volume spacer, breath-activated and dry powder inhalers in older people. Age and ageing 1999; 28: 481-484.
2. Lenny J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respiratory Medicine 2000; 94: 496-500.
3. Price D, Pearce L, Powell SR et al. Handling and acceptability of the Easi-Breathe device compared with a conventional metered dose inhaler by patients and practice nurses. International Journal of Clinical Practice 1999; 53(1): 31-36.
4. Shrestha M, Parupia H, Andrews B et al. Metered dose inhaler technique of patients in an urban ED: prevalence of incorrect technique and attempt at education. American Journal of Emergency Medicine 1996; 14(4): 380-384.
5. Cochrane MG, Bala MV, Downs KE et al. Inhaled corticosteroids for asthma therapy: patient compliance, devices and inhalation technique. Chest 2000; 117: 542-550.
6. Kamps A WA, van Ewijk B, Jan Roorda R, Brand PL. Poor inhalation technique, even after inhalation instructions in children with asthma. Pediatric Pulmonology 2000; 29(1): 39-42.
7. Scarfone RJ, Capraro GA, Zorc JJ et al. Demonstrated use of metered-dose inhalers and peak flow meters by children and adolescents with acute asthma exacerbations. Archives of Pediatrics & Adolescent Mediane 2002; 156: 378-383.
8. Luskin AT, Bukstein D, Ben-Joseph R. The relationship between prescribed and delivered doses of inhaled corticosteroids in adult asthmatics. Journal of Asthma 2001; 38(8): 645-655.
9. Tomlinson HS, Corlett SA, Allen MB, Chrystyn H. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge. British Journal of Clinical Pharmacology 2005; 60(6): 605-610.
10. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. European Respiratory Journal 2002; 19(2): 246-251.
11. Lindgren S, Bake B, Larsson S. Clinical consequences of inadequate inhalation technique in asthma therapy. European Journal of Respiratory Disease 1987; 70: 93-98.
12. Price D, Thomas M, Mitchell G et al. Improvement of asthma control with a breath-actuated pressurised metered dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metered dose inhaler (MID) or a breath-actuated device. Respiratory Medicine 2003; 97: 12-19.
13. Kelloway JS, Wyatt RA. Cost-effectiveness analysis of breath-actuated metered dose inhalers. Managed Care Interface 1997; 10(9): 99-107.
14. Langley PC. The technology of metered-dose inhalers and treatment. Clinical Therapeutics 1999; 21(1): 236-253.
15. Haycox A, Mitchell G, Niziol C et al. Cost effectiveness of asthma treatment with a breath-actuated pressurised metered dose inhaler (BAI) - a prescribing claims study of 1856 patients using a traditional pressurised metered dose inhaler (MDI) or a breath-actuated device. Journal of Medical Economics 2002; 5: 65-77.
16. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58(1):i1-i94.
17. Global Initiative for Asthma (GINA). Asthma management and prevention. NHLBI, NIH Bathesda, Maryland. 1995; publication 96-3659A.
18. CACI, http://www.caci.co.uk.
19. Lewis M, Patwell J, Briesacker B. The role of insurance claims databases in drug therapy outcomes research. Pharmacoeconomics 1993; 4: 323-330.
20. Sackett D. Bias in analytical research. Journal of Chronic Disease 1979; 32: 51-63.
21. Green S, Byar D. Using observational data from registries to compare treatment: the fallacy of omnimetrics. Statistics in Medicine 1984; 3: 361-370.
22. Curtis L, Netten A. Unit Costs of Health and Social Care Personal Social Services Research Unit, University of Kent, Canterbury, 2002.
23. Categories of ACORN, http://caci.co.uk/acorn